Irwin Stone, D.Sc.
One thing certain in any long-term research program is that no
matter where you start, you have no idea how it will end. In 1934,
as head of a newly formed commercial enzyme and fermentation research
laboratory, I had the opportunity to investigate the problem in
industrial technology of improving the flavor stability of packaged
beer. The problem was successfully solved by using the unique
chemical properties of a new substance discovered and described
only two years earlier by Albert Szent Gyorgyi, M.D., Ph.D., -
Ascorbic Acid. I went on to be awarded the first United States
Patents on industrial uses of ascorbic acid in 1939, while Albert
Szent-Gyorgyi received the Nobel Prize in Medicine in 1937 for
his discoveries. I had not the slightest inkling at that time,
that thirty-one years later in 1965 1 would be describing a hitherto
unrecognized human birth defect due to the presence of a mutated
defective gene in the human gene pool. If anyone asks me the embarrassing
question, "What took you so long?", my answer is the lack of proper
funding for my medical work. My industrial sponsors were not interested
in the genetics of scurvy, and what do you do when you are two
centuries ahead of the medical grant peer reviewers who hold the
purse strings? I did the best I could on my own time using my
own meager funds. In the period 1934 to 1965, one research idea
led to another and many biochemical industrial and enzymatic problems
were solved, resulting in about sixty technical publications and
a score of U.S. Patents. I early became aware, from my library
research on the medical aspects of ascorbic acid that the recommended
low daily intakes, the so-called "RDA's", of the multifunctional
ascorbate-ion, which most everyone succumbing to the misleading
1912 nutritional propaganda regarded as the trace food substance,
"vitamin C", seemed far below what a chemist would expect to be
required for optimum reaction rates for a wide variety of vital
biochemical functions in a 70 kg human. Besides, I searched the
literature of the nutritionists, who with the unlimited financial
backing of the food industry, had dominated the field of scurvy
research in the 20th century. I could not find a single paper
that reported a properly designed, long-term double blind test
to determine the optimum daily human requirements for ascorbic
acid in health and disease and under a variety of stresses. Even
now, over forty years after commercial pure ascorbic acid became
available, nutritionists have not supplied us with this vitally
important critical data. Instead, they have become so locked-in
to their antiquated 1912 nutritional hypothesis, that they assume
that scurvy can only be cured by dietary means by consuming a
"normal" diet with plenty of fresh fruits and vegetables. The
actual levels of ascorbate in foodstuffs are so low that when
they calculated the adult RDA's they arrived at figures varying
from 45 to 75 milligrams of ascorbate (vitamin C) a day, for the
past several decades. This miniscule daily RDA is published, with
a new edition every five years, by the National Academy of Sciences
in Washington, D.C. in the publication entitled "Recommended Dietary
Allowances", which has a semi-official status and is the bible
for the nutritionists and the Food and Drug Administration. The
latest edition gives the adult RDA for ascorbic acid as 60 milligrams
a day, which they claim includes a "factor of safety", For overcoming
the stresses of pregnancy, they recommend adding another 20 milligram
intake for the pregnant female. More about this later when we
discuss the Sudden Infant Death Syndrome.
Two M.D.'s who early and independently recognized the physiological
inadequacy of these miniscule daily ascorbic acid intakes were
the scholarly Canadian physician, William J. McCormick, M.D.,
who had been practicing medicine since 1904, and the Megascorbic
Medical Pioneer, the Reidsville North Carolina, "country doctor",
Frederick R. Klenner, M.D. Dr. Klenner saved his own daughter
from death and paralysis in the 1947 polio epidemic with mega
doses of ascorbate. Both these great physicians published their
views and case histories widely and I had the good fortune to
meet both of them. While their innovative views fell upon the
deaf ears of orthodox medicine and were completely ignored, they
made a lasting impression on me and were a great factor in my
continuing to work in this strange and frustrating field of orthodox
medicine, where the bulk of the practitioners seemed to have no
desire to learn anything new and innovative, especially from a
non-M.D. chemist. Since the 1930's, when ascorbic acid first became
commercially available, I and my family became our own guinea
pigs, experimenting with the effect of these mega doses on our
health and well being. As the prices of the ascorbate dropped
our daily intake rose. I also early developed a megascorbic procedure
for aborting the common cold, which in my tests was more than
95 percent effective. I haven't had a cold in over forty years.
Starting about the mid-1940's, I had my laboratory repackage ascorbic
acid and sodium ascorbate in four ounce bottles which we sold
to our fellow employees at cost. I noticed a drop in absenteeism
due to sickness, and when they were on the job they seemed to
have more stamina, were less tired and seemed to be smarter than
their scorbutic counterparts.
In May, 1960, at a meeting in Minneapolis, I was elected Vice
President of the American Society of Brewing Chemists, an organization
in which I had long been active. This meant that I would become
President in 1962-1963. After the meeting we decided to vacation
in the Black Hills of South Dakota and see Mount Rushmore, but
we never got there. Outside of Rapid City, South Dakota, we had
a very serious automobile accident when a drunk driving on the
wrong side of the road drove her car at 80 miles an hour into
a head-on collision with ours. Both my wife and I were seriously
injured and the only reason we survived was the fact that we had
been regularly taking daily megadoses of ascorbate for decades.
We never went into the deep shock that kills most accident victims
and I was able to experimentally verify ascorbate's great healing
power and survival value by taking about fifty to sixty grams
a day of ascorbate during our hospitalization. My wife recovered
quickly and acted as my "nurse". I went through five serious operations
without any surgical shock and my multiple bone injuries healed
so fast that we were able to leave the hospital in less than three
months; take a 2,000 mile train trip home and I was back at work
running my lab in two months more. I left the hospital, under
my own steam, on crutches, walking on legs that the doctors originally
predicted I would not be able to stand on for at least a year.
My larynx was damaged by part of the steering wheel inflicting
a deep throat wound, and the doctors despaired that I would ever
talk again. With the help of megascorbics, this problem slowly
resolved and I was able to assume the public speaking duties of
the President of a Scientific Society with a voice of a slightly
different timbre. If you ask my wife, she will tell you that I
now talk too much!
Most important, this accident impressed on me the need for immediate
publication of the medical data on Megascorbics; and the genetics
of scurvy that I had been collecting for years. Originally I had
planned to publish my medical ideas after I would be mandatorily
retired at age 65 from my industrial connections.
The first four papers describing the genetics of scurvy and the
human "inborn error of carbohydrate metabolism", Hypoascorbemia,
appeared in the period 1965-1967. Hypoascorbemia is a potentially
fatal genetic liver-enzyme disease, a human birth defect caused
by a defective gene in the human gene pool for the synthesis of
the active enzyme protein, L-gulonolactone oxidase (GLO). This
defective gene appears to be present in 100 percent of the human
population and is the biochemical reason that the human liver
is unable to complete the normal stress-related mammalian biochemical
conversion of blood sugar, glucose, into ascorbic acid.
This is an extremely vital biochemical pathway that proceeds normally
and continuously throughout the lifetime of the non-Primate mammals
carrying the intact gene for GLO, producing large stress-related
daily amounts of ascorbate in the liver, which is funnelled directly
into the blood stream to give the necessary high blood and tissue
levels of ascorbate required for the maintenance of biochemical
homeostasis throughout the body.
Mammals with the intact gene for GLO also have an inherited biochemical
feedback mechanism that increases the liver synthesis of ascorbate
in response to various stresses. This feedback mechanism was a
great factor in assuring the survival and dominance of the Earth
by the mammals during the past 165 million years of evolution.
Some of my later papers indicate that a large group of mammals
became extinct during this evolution because they could not make
enough daily ascorbate for survival. Homo sapiens have paid a
very high cost in deaths, disease and misery during the past few
million years of evolution in trying to survive without the benefit
of the intact gene for GLO. I regard Homo as our most endangered
mammal, scheduled for extinction in the 21st Century from overpopulation
pollution, unless humans take evolutionary destiny into their
own hands and convert themselves into the robust human subspecies,
Homo Sapiens Ascorbicus. Read my papers on "Homo Sapiens Ascorbicus";
I've published several since 1979.
1 would like to show you at this point an exhibit of three test
tubes. The first tube contains the amount of ascorbic acid that
a 70 kg human produces in its liver each day. It is an empty tube.
The second tube is over half full of ascorbic acid, which is the
13,000 mg that an unstressed 70 kg goat produces in its liver
each day. Under stress the test tube would not be large enough
to hold all the ascorbate produced. The small third tube contains
the current RDA for ascorbic acid - 60 milligrams, barely enough
to cover the bottom of the tube. This is the daily intake for
70 kg human adults recommended by nutritionists, physicians and
the Food and Nutrition Board of the National Academy of Sciences
in Washington, D.C. My recommendations for the daily intake of
ascorbate would be close to the amounts synthesized daily by the
mammals with the intact gene for GLO. In times of stress the intakes
are increased and the extent of increase can be estimated by the
bowel tolerance procedure of Dr. Robert Cathcart. I have been
taking about 20 grams of ascorbate a day for many years which
is over three hundred times the current RDA, enjoying full health
during this time. In my 1983 paper on the effect of megascorbate
on Aging and Alzheimer's disease, I cite as shining examples of
the value of this daily megascorbic regimen in maintaining a long
healthy active, disease-free life: they are my long time friends
and colleagues, Albert Szent-Gyorgyi, 91; Linus Pauling, 83; Frederick
Klenner, 77; and myself, 77; all still working hard and none showing
the slightest
trace of Alzheimer's.
I regard as one of the major blunders of 20th Century medicine
the full acceptance of these inaccurate RDA's without conducting
long-term double blind studies on their accuracy and effectiveness
in health and disease. This blunder is further compounded by the
medical schools teaching these antiquated ideas on scurvy to our
future doctors, two decades after I showed that scurvy was a deadly
problem in medical genetics. For the first time in millions of
years, it was possible in the early 1940's to "cure" scurvy when
inexpensive pure ascorbic acid became commercially available.
Medicine did nothing at this time because there was no one around
at that time with sufficiently accurate knowledge of the genetics
of scurvy to guide them. This excuse was eliminated with the publication
of my 1965-67 papers on the genetics of scurvy, but they still
took no steps to fully correct this human birth defect, and eliminate
the health threatening effects of this widespread iatrogenic epidemic
of Chronic Subclinical Scurvy.
Except for medical friends, colleagues and many sick non-medical
lay persons, the bulk of the medical establishment ignored this
work and to them it was "business as usual." They never gave themselves
the opportunity to observe the improved therapeutic results they
would obtain when their sick patients were free of the debilitating
lifelong Chronic Subclinical Scurvy.
In the 1960's I interested Dr. Linus Pauling in my early work
and my technique for aborting the common cold. He confirmed my
work and his life has never been the same since. This led to the
publication of his 1970 book, Vitamin C and the Common Cold, which
in later editions became Vitamin C, The Common Cold and The Flu.
In 1979, Cancer and Vitamin C, appeared which described his cancer
collaboration with Dr. Ewan Cameron.
I started publication of my megascorbic leukemia ideas in 1974.
In 1975, as a result of my collaboration with my good friend,
Wendell 0. Belfield, D.V.M., we wrote a paper showing the need
for and the good results obtained with megascorbic therapy in
cats and dogs, even though they had the intact gene for GLO. We
found that cats and dogs were poor producers of daily ascorbate
in their livers. They made about one-fifth the daily amount produced
in other mammals with the intact gene for GLO. For many years,
Wendell had been independently using Megascorbics with great success
in canine distemper (viral encephalitis) and in hip dysplasia
in large dogs. He also recently megascorbically solved the problem
of cat leukemia, the number one killer of pet cats. He, like his
counterparts in human medicine, has had his problems with the
veterinary medical establishment. His two books on dogs (1981)
and cats (1983) are classics in maintaining these pets in good
health.
My cancer suggestions were published in 1974, 1976,1977 and 1981.
In my 1983 paper, presented at the Orthomolecular Medical Society
meeting in San Francisco, I reported on the remarkable case of
Joseph Kieninger, chemist and patent attorney, terminal cancer
victim turned successful therapist. Joe is a prostatic cancer
victim, whose cancer has spread throughout his body. He was declared
terminal in 1977 and given about one year to live. By his innovative
daily treatments both systemic (beginning with 80 to 100 grams
sodium ascorbate a day, every day) and topical megascorbic applications,
he has survived to the present, living a pain-free, relatively
normal life, going to work each day and feeling good most of the
time. I believe Joe is a prototype for survival in terminal disease
and has shown us a new way of handling these highly scorbutic
patients that Medicine has given up, and prevent them from dying
of scurvy. Joe, a keen observer, wrote up and submitted his case
history to the New England Journal of Medicine, but they returned
his manuscript and refused publication. If I am correct in thinking
of Joe as a terminal disease prototype, then this would put a
different complexion on the Hospice Movement. Instead of terminal
patients going to a hospice to die in dignity, they would go to
be taught the inexpensive megascorbate regimen on how to live
in dignity, and then go home and practice this regime for the
rest of their lives.
No discussion of cancer would be complete without mention of my
friend and colleague, Henry L. Newbold, M.D., of New York City,
who in 1979 published his book Vitamin C Against Cancer (Stein
and Day, New York). It is now in an inexpensive paperback edition
and should be read by every cancer victim as a "second opinion";
it may be life saving.
In 1973 I became acquainted with the work of Archie Kalokerinos,
M.D. and Glen Dettman, Ph.D., of Australia on their megascorbic
solution of the Sudden Infant Death Syndrome (SIDS). SIDS was
also solved earlier in a similar manner by Dr. Klenner. My work
indicates that because of the poor correction of the birth defect
for GLO, every baby is born after a nine month bout with intrauterine
scurvy. The first result of this is the Sudden Infant Death Syndrome.
Klenner and Kalokerinos found that by increasing the daily intake
of ascorbate by the pregnant mother (15 grams/day) and the neonate
(100 mg/day) that SIDS could be eliminated. Publication of this
simple, harmless procedure in the Australian medical literature
brought down the wrath of the Australian medical establishment
on these investigators. They refused to test Kalokerinos' procedure
and allowed babies to die needlessly, because there is no other
effective treatment for SIDS. I thought that this would never
happen in American Medicine, but I was wrong and it is happening
here right now. The orthodox medical establishment is the same
the world over. About 10,000 babies die each year in the U.S.
from SIDS. To stem this slaughter, Drs, Kalokerinos and Dettman
have come to the U.S. on biannual nationwide lecture tours since
1976, and they will be returning again in September 1984. Ten
years ago Dr. Kalokerinos' book, Every Second Child, appeared
in Australia. 1981 saw the publication of an American paperback
edition (Keats Pub. Co- New Canaan, CT 06840). Since the publication
of their book in 1974, 100,000 babies have died, sacrificed to
medical bias and professional stubbornness and callousness. It
is unbelievable. This really is nothing new to me because I have
constantly come up against similar hostility from the Medical
Establishment when I tried to have clinical trials conducted after
publication of my papers on leukemia (1974), veterinary medicine
(1975), smoking (1976), cancer (1976), drug addiction (1977),
sudden death (1978), endogenous interferon treatment of cancer
and the viral diseases (1979-1981), multiple sclerosis (1982),
aging and Alzheimer's disease (1983) and AIDS (1993).